These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1057654)

  • 21. Reactivity of gastric cancer patients in leucocyte migration inhibition tests to 3M KCl extracts from gastric tumor.
    Kojima O; Oh A; Kitagawa N; Uehara Y; Nishioka B; Fujita Y; Majima S
    Jpn J Surg; 1981; 11(6):413-21. PubMed ID: 7035728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of human tumor-associated antigens by the leukocyte migration in agarose assay.
    Boddie AW; Urist MM; Chee DO; Holmes C; Morton DL
    Int J Cancer; 1976 Aug; 18(2):161-7. PubMed ID: 60286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.
    Halliday WJ; Maluish A; Isbister WH
    Br J Cancer; 1974 Jan; 29(1):31-5. PubMed ID: 4820944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
    Winter M; Nelson DS; Milton GW
    Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte migration inhibition assay in patients with prostate adenocarcinoma.
    Wright GL; Schellhammer PF; Faulconer RJ; Reid JW; Brassil DN; Sieg SM
    Prostate; 1981; 2(2):121-31. PubMed ID: 6170963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human leukocyte migration in agarose by kcl extracts of carcinoma of the lung.
    Boddie AW; Holmes EC; Roth JA; Morton DL
    Int J Cancer; 1975 May; 15(5):823-9. PubMed ID: 1140874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human malignant melanoma antigenic properties of phenol water extracts.
    Suter L; Tilkorn H; Kövary PM
    Arch Dermatol Res; 1979 Feb; 264(1):37-47. PubMed ID: 443860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
    Hollinshead AC
    Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cellular immunity in melanomalignome (author's transl)].
    Fritz J; Grond K; Tilz GP
    Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular immunity to breast carcinoma and malignant melanoma.
    Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
    Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
    Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
    J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
    Emmrich F; Ambrosius H
    Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
    Plain MJ; Whitehead RH; Jose DG
    Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
    Lee C; Chen S; Lin T
    Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-directed immunity in human neuroblastoma.
    Morrison LJ; Cochran AJ; Baird GM; Campbell AM; Willoughby ML
    Am J Pediatr Hematol Oncol; 1982; 4(1):3-9. PubMed ID: 7046494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoassessment of patients with gastric cancer. Using leukocyte migration inhibition (LMI) test.
    Kojima O; Uehara Y; Majima T; Ikeda E; Nishioka B; Fujita Y; Majima S
    Gastroenterol Jpn; 1983 Aug; 18(4):303-9. PubMed ID: 6628918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.